NASDAQ:DCOY

Biotechnology·Finance·NASDAQ:DCOY·News·Stock Market

DCOY Sets May 22 Vote, Puts Focus Back on Thinly Traded Stock

Decoy Therapeutics holders of record as of May 22 will be eligible to vote at the July 14 annual meeting. The biotech reported $7.8 million in cash and a $2.2 million first-quarter net loss, warning of “substantial doubt” about its ability to continue as a going concern. DCOY shares rose sharply this week but remain down 95% over the past year.

May 22, 2026

Guzman Y Gomez Shares Plunge 37% but Show Strong Growth Prospects
May 29, 2026, 9:18 PM EDT. Guzman Y Gomez Ltd (ASX: GYG), an Australian Mexican restaurant chain, has seen its shares fall over 37% in the past year and more than 55% since December 2024. Despite the volatility, the company has ambitious growth plans, aiming to expand its Australian restaurant count from 242 to 1,000 within 20 years. It reported 20% network sales growth and 6.6% comparable sales growth in Australia in Q3 FY26, with underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) expected to rise 29% year-on-year to about AUD 85 million. Asian operations, particularly in Japan and Singapore, are growing at 15% per year but remain a small portion of total sales. Rising profit margins could further boost future earnings, making GYG a notable opportunity outside the volatile tech sector.